LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

Kodu・Aktsiate loetelu・VolitionRX Ltd

VolitionRX Ltd

Suletud

0.32 3.23

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.31

Max

0.33

Põhinäitajad
By Trading Economics
Sissetulek	904K -5.4M
Müük	221K 627K
Kasumimarginaal	-862.425
Töötajad	85
EBITDA	-475K -5.5M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+603.13% upside

Turustatistika
By TradingEconomics
Turukapital	-8.1M 39M
Eelmine avamishind	-2.91
Eelmine sulgemishind	0.32

VolitionRX Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. nov 2025, 21:54 UTC

Omandamised, ülevõtmised, äriostud

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

24. nov 2025, 18:26 UTC

Suurimad hinnamuutused turgudel

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

24. nov 2025, 23:49 UTC

Market Talk

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

24. nov 2025, 23:08 UTC

Market Talk

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

24. nov 2025, 23:08 UTC

Market Talk

Global Equities Roundup: Market Talk

24. nov 2025, 22:56 UTC

Market Talk

Tulu

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

24. nov 2025, 22:47 UTC

Market Talk

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

24. nov 2025, 22:36 UTC

Market Talk

Tulu

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

24. nov 2025, 22:32 UTC

Tulu

Webco Industries 1Q EPS $6.79 >WEBC

24. nov 2025, 22:07 UTC

Tulu

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

24. nov 2025, 22:07 UTC

Tulu

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q Adj EPS 78c >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q Rev $17.9B >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q EPS 79c >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Rev $17.9B >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Net $740.6M >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Adj EPS 78c >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q EPS 79c >ATD.T

24. nov 2025, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

24. nov 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

24. nov 2025, 21:44 UTC

Market Talk

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

24. nov 2025, 21:39 UTC

Omandamised, ülevõtmised, äriostud

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

24. nov 2025, 20:42 UTC

Market Talk

Oil Futures Snap Three-Session Losing Streak -- Market Talk

24. nov 2025, 20:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

24. nov 2025, 19:56 UTC

Omandamised, ülevõtmised, äriostud

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

24. nov 2025, 18:26 UTC

Market Talk

Crude Futures Move Higher in Choppy Trade -- Market Talk

24. nov 2025, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

24. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

24. nov 2025, 17:09 UTC

Market Talk

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

24. nov 2025, 16:52 UTC

Omandamised, ülevõtmised, äriostud

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

VolitionRX Ltd Prognoos

Hinnasiht

By TipRanks

603.13% tõus

12 kuu keskmine prognoos

Keskmine 2.25 USD 603.13%

Kõrge 3 USD

Madal 1.5 USD

Põhineb 3 Wall Streeti analüütiku instrumendi VolitionRX Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi VolitionRX Ltd aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.